Breast Cancer Issues Conference Press Release

For Immediate Release

20th Annual Susan G. Komen Oregon and SW Washington Regional Breast
Cancer Issues Conference
Presents Kathleen Dunham, MD as Keynote Speaker

November 14, 2017, Portland, OR – Komen Oregon and SW Washington is pleased to
announce that Kathleen Dunham, MD, Compass Oncology, will be the keynote
speaker for the organization’s 20th Annual Regional Breast Cancer Issues Conference
on March 17, 2018.

Dr. Dunham’s keynote session will focus on the psychology of surgical decision
making after a breast cancer diagnosis, and how the emotional aspects of cancer,
bias, and belief shape our decisions. Dr. Dunham joined Compass Oncology as a
Breast Oncology Surgeon in 2016 after completing a fellowship at Baylor University
Medical Center. She obtained her medical degree from Royal College of Surgeons in
Ireland, where she graduated with high honors and was awarded the Jack Flanagan
Medal in Neurology, Psychology and Gerontology.

This daylong event brings together survivors, forever fighters, co-survivors, and
healthcare professionals to discuss emerging research, treatment options, and
quality of life issues with nationally respected experts. The event will feature a
track in Spanish, and will be simulcast in six cities, reaching new audiences.

Registration and more information are available at

About Susan G. Komen Oregon and SW Washington
In the last 26 years, the local organization has funneled nearly $19.5 million into
programs that prioritize the importance of improving and building on the quality of
life for survivors and fighters, emphasize the value of early detection and
screenings, as well as provide financial assistance for access to treatment. Another
$12.2 million has been dedicated, locally, to cutting edge research.

About Susan G. Komen
Susan G. Komen is the world’s largest breast cancer organization, funding more
breast cancer research than any other nonprofit while providing real-time help to
those facing the disease. Nationally, since 1982, Komen has funded $3 billion in
funding to research, screening, education, treatment and psychosocial support
programs serving millions of people in more than 30 countries worldwide. More
information is available at